88 FR 174 pgs. 62385-62386 - Meeting of the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment
Type: NOTICEVolume: 88Number: 174Pages: 62385 - 62386
Pages: 62385, 62386FR document: [FR Doc. 2023-19542 Filed 9-8-23; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: Health Resources and Services Administration
Official PDF Version: PDF Version
[top]
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Meeting of the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment
AGENCY:
Health Resources and Services Administration (HRSA), Department of Health and Human Services (HHS).
ACTION:
Notice.
SUMMARY:
[top] In accordance with the Federal Advisory Committee Act, this notice announces that the Secretary's Centers for Disease Control and Prevention (CDC)/HRSA Advisory Committee on HIV, Viral Hepatitis and
DATES:
Tuesday, October 24, 2023, 9 a.m. to 4 p.m. Eastern Time (ET); and Wednesday, October 25, 2023, 9 a.m. to 3 p.m. ET.
ADDRESSES:
This meeting will be hybrid, held both virtually through Zoom and in person at 5600 Fishers Lane, Pavilion Rooms 5A02, 5A03, and 5A04, Rockville, Maryland 20857. Advance registration is required to attend. Please visit the meeting website to register. The in-person registration deadline is Monday, October 16, 2023, at 5 p.m. ET; registration for virtual attendance will remain open. Prior to the meeting, each individual registrant will receive a registration confirmation along with an access link to the virtual meeting location.
FOR FURTHER INFORMATION CONTACT:
Shalonda Collins, Public Health Analyst, HIV/AIDS Bureau, HRSA, (301) 945-0835; CHACAdvisoryComm@hrsa.gov .
SUPPLEMENTARY INFORMATION:
CHAC provides advice and recommendations to the Secretary of HHS (Secretary) on policy, program development, and other matters of significance concerning the activities under Section 222 of the Public Health Service Act, 42 U.S.C. 217a.
The purpose of the CHAC is to advise the Secretary of HHS, CDC Director, and HRSA Administrator regarding objectives, strategies, policies, and priorities for the prevention and treatment of HIV, viral hepatitis, and other STDs, including surveillance, epidemiologic, behavioral, health services, and laboratory research, identification of policy issues related to professional eduction, patient healthcare delivery, and prevention services; agency policies regarding health care delivery, research and training; strategic issues influencing the ability of CDC and HRSA to fulfill their missions' programmatic efforts to prevent and treat HIV, viral hepatitis, and other STDs; and support to CDC and HRSA in their development of responses to emerging health needs related to these issues.
During the October 24-25, 2023, meeting, CHAC will discuss issues related to reducing barriers and improving outcomes in HIV and Hepatitis C co-infection, payment models for addressing social determinants of health, incorporating stigma reduction in HIV care and treatment, as well as other special presentations. Agenda items are subject to change as priorities dictate. Refer to the CHAC meeting information page for any updated information concerning the meeting.
Members of the public will have the opportunity to provide comments. Public participants may also submit written statements as further described below. Oral comments will be honored in the order they are requested and may be limited as time allows. Requests to submit a written statement or make oral comments to CHAC should be sent via the meeting website at https://targethiv.org/ta-org/chac . Requests for oral comment must be received by October 17, 2023, at 5 p.m. ET to be considered. Written comments may be submitted to Shalonda Collins at the email address and/or phone number listed above prior to and up to 10 business days after the meeting. Visit the meeting information page for additional details: https://targethiv.org/ta-org/chac .
Individuals who plan to attend and need special assistance or another reasonable accommodation should notify Shalonda Collins at the email address and/or phone number listed above at least 10 business days prior to the meeting.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2023-19542 Filed 9-8-23; 8:45 am]
BILLING CODE 4165-15-P